|
TSPAN13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.09019999589211E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.83999998255069E-09 |
| Normal-vs-Stage2 |
2.623900E-02 |
| Normal-vs-Stage3 |
1.091810E-02 |
| Normal-vs-Stage4 |
2.024700E-03 |
| Stage1-vs-Stage2 |
1.501570E-01 |
| Stage1-vs-Stage3 |
7.624000E-01 |
| Stage1-vs-Stage4 |
4.694400E-01 |
| Stage2-vs-Stage3 |
5.261000E-01 |
| Stage2-vs-Stage4 |
1.583050E-01 |
| Stage3-vs-Stage4 |
4.371400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.81109999511875E-08 |
| Normal-vs-AfricanAmerican |
4.738300E-03 |
| Normal-vs-Asian |
2.216400E-01 |
| Caucasian-vs-AfricanAmerican |
5.756600E-01 |
| Caucasian-vs-Asian |
3.171800E-01 |
| AfricanAmerican-vs-Asian |
3.010200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.71930000031951E-07 |
| Normal-vs-Female |
1.92764999999984E-05 |
| Male-vs-Female |
3.677600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.903530E-02 |
| Normal-vs-Age(41-60Yrs) |
1.02930000001056E-06 |
| Normal-vs-Age(61-80Yrs) |
3.20019999999754E-06 |
| Normal-vs-Age(81-100Yrs) |
1.165600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.513000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.106200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.886600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.003000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.687000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.064000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.151500E-02 |
| Normal-vs-Grade 2 |
2.3845999952421E-08 |
| Normal-vs-Grade 3 |
1.644070E-03 |
| Normal-vs-Grade 4 |
6.815500E-03 |
| Grade 1-vs-Grade 2 |
1.211570E-01 |
| Grade 1-vs-Grade 3 |
8.467900E-02 |
| Grade 1-vs-Grade 4 |
6.970200E-01 |
| Grade 2-vs-Grade 3 |
6.756800E-03 |
| Grade 2-vs-Grade 4 |
4.371800E-01 |
| Grade 3-vs-Grade 4 |
8.868000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.81700000004781E-07 |
| Normal-vs-ccB subtype |
7.409400E-04 |
| ccA subtype-vs-ccB subtype |
7.700200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.60989999999206E-05 |
| Normal-vs-N1 |
1.943640E-01 |
| N0-vs-N1 |
2.248600E-01 |
|
|
